Invention Grant
- Patent Title: Wound spray
-
Application No.: US14131022Application Date: 2012-07-23
-
Publication No.: US10646613B2Publication Date: 2020-05-12
- Inventor: Michael Sander , Harald Potzschke
- Applicant: Michael Sander , Harald Potzschke
- Applicant Address: SE Göteburg
- Assignee: MÖLNLYCKE HEALTH CARE AB
- Current Assignee: MÖLNLYCKE HEALTH CARE AB
- Current Assignee Address: SE Göteburg
- Agency: Kilpatrick Townsend & Stockton LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@718ad803
- International Application: PCT/EP2012/003086 WO 20120723
- International Announcement: WO2013/013799 WO 20130131
- Main IPC: A61L26/00
- IPC: A61L26/00 ; A61M1/34 ; A61K38/42 ; A61M35/00 ; C07K14/805
Abstract:
The present invention refers to a composition, comprising hemoglobin or myoglobin, wherein in at least 40% of said hemoglobin or myoglobin the oxygen binding site is charged by a non-O2 ligand, and at least one further ingredient, a method for preparing said composition and the use of hemoglobin or myoglobin charged with a non-oxygen ligand for external treatment of wounds.
Public/Granted literature
- US20140221944A1 WOUND SPRAY Public/Granted day:2014-08-07
Information query
